Turn this list into an evaluation

Each entry is an FDA submission, not a distinct commercial offer. Inspect the exact record before comparing evidence, asking for a quote or planning an integration.

Prepare with a buyer guide:

Clinical guide links appear when this list contains a current reviewed example. They do not classify or endorse the other entries. All buyer guides · Compare exact records · Documented families

FDA-cleared K254013

SubtleHD-PET (1.x)

Subtle Medical, Inc.

PET image-processing software that reduces image noise while preserving the original images for clinical review.

Modality
PET/SPECT/Nuclear Medicine
Anatomy
Whole body and the body regions represented in PET studies
Decision
2026-05-14
FDA-cleared K260524

uMI Panvivo (uMI Panvivo LS); uMI Panvivo (uMI Panvivo); uMI Panvivo (uMI Panvivo S); uMI Panvivo (uMI Panvivo EX); uMI Panvivo (uMI Panvivo ES)

Shanghai United Imaging Healthcare Co., Ltd.

Authorized purpose: uMI Panvivo variants acquire and display PET and CT information for anatomical and functional imaging, radiopharmaceutical distribution, attenuation correction, and the labeled body-region workflows.

Modality
PET/SPECT/Nuclear Medicine
Anatomy
Whole body; brain; head and neck; heart; lung; breast; gastrointestinal; urinary; genital; and musculoskeletal anatomy
Decision
2026-04-03
FDA-cleared K253564

uMI Panvivo (uMI Panvivo); uMI Panvivo (uMI Panvivo S); uMI Panvivo (uMI Panvivo EX); uMI Panvivo (uMI Panvivo ES)

Shanghai United Imaging Healthcare Co., Ltd.

Authorized purpose: uMI Panvivo PET/CT acquires anatomical CT and functional PET images of radiopharmaceutical distribution for qualified diagnostic and treatment-planning workflows, including labeled lung-cancer-screening use.

Modality
PET/SPECT/Nuclear Medicine
Anatomy
Whole body, head and neck, cardiac, and other labeled PET/CT regions
Decision
2026-02-13
FDA-cleared K253023

BIOGRAPH One

Siemens Healthineers AG

Authorized purpose: BIOGRAPH One with syngo MR XB10 combines metabolic or physiologic PET information with MR anatomy, MR-based attenuation correction, fused alignment, and support for treatment planning and interventions.

Modality
PET/SPECT/Nuclear Medicine
Anatomy
Multi-region
Decision
2026-01-15
FDA-cleared K254001

VERITON CT 300 Series Digital SPECT/CT System (VERITON CT 316/364); VERITON CT 400 Series Digital SPECT/CT System (VERITON CT 416/464)

Spectrum Dynamics Medical, Ltd.

Authorized purpose: VERITON CT 300/400 Series combines SPECT and CT for detection, localization, diagnosis, staging, restaging, organ-function assessment, therapy planning, guidance, and monitoring. Optional VERITAS.AI applies locked noise-reduction models to reconstructed SPECT images.

Modality
PET/SPECT/Nuclear Medicine
Anatomy
Multi-region
Decision
2026-01-13
FDA-cleared K253532

TruSPECT Processing Station

Spectrum Dynamics Medical, Ltd.

Authorized purpose: TruSPECT Processing Station receives, transfers, displays, stores, and processes radioisotope-tracer images for trained professionals; TruClear AI SPECT enhancement supports the existing image-processing workflow and does not replace clinical judgment.

Modality
PET/SPECT/Nuclear Medicine
Anatomy
Heart, organs, and body regions represented in SPECT studies
Decision
2025-12-30
FDA-cleared K251370

Cartesion Prime (PCD-1000A/3) V10.21

Canon Medical Systems Corporation

Authorized purpose: Cartesion Prime PET/CT acquires cross-sectional CT images and PET radiopharmaceutical-distribution images and includes AiCE-i PET processing and a neural-network respiratory-gating workflow for supported examinations.

Modality
PET/SPECT/Nuclear Medicine
Anatomy
Whole body, head, neck, cardiac, and other labeled PET/CT regions
Decision
2025-12-01
FDA-cleared K243919

Voxel Dosimetry (00859873006226)

Hermes Medical Solutions AB

Authorized purpose: Voxel Dosimetry 3.1 calculates voxel-level absorbed-dose maps from nuclear-medicine images acquired after administration of FDA-approved therapeutic radiopharmaceuticals and supports single-time-point or time-series workflows.

Modality
PET/SPECT/Nuclear Medicine
Anatomy
Multi-region
Decision
2025-07-30
FDA-cleared K251839

uMI Panvivo (uMI Panvivo); uMI Panvivo (uMI Panvivo S)

Shanghai United Imaging Healthcare Co., Ltd.

Authorized purpose: uMI Panvivo and Panvivo S acquire and display PET and CT information for anatomical and functional imaging, radiopharmaceutical distribution, and the labeled oncology, cardiology, neurology, infection, inflammation, radiotherapy-planning, and interventional workflows.

Modality
PET/SPECT/Nuclear Medicine
Anatomy
Whole body; brain; head and neck; heart; lung; breast; gastrointestinal; urinary; genital; and musculoskeletal anatomy
Decision
2025-07-17
FDA-cleared K251528

syngo.via MI Workflows; Scenium; syngo MBF

Siemens Medical Solutions USA, Inc.

Authorized purpose: syngo.via MI Workflows, Scenium, and syngo MBF provide PET, SPECT, nuclear-medicine, CT, and MR viewing, manipulation, quantification, longitudinal comparison, and analysis for oncology, cardiology, neurology, organ function, and selected radiation-planning support.

Modality
PET/SPECT/Nuclear Medicine
Anatomy
Multi-region
Decision
2025-07-03
FDA-cleared K251153

Aurora

GE Medical Systems Israel

Authorized purpose: Aurora is a SPECT/CT system for nuclear-medicine uptake imaging, standalone CT, anatomical localization, attenuation correction, diagnosis, staging, therapy planning, guidance, and monitoring. K251153 adds deep-learning kidney segmentation to dynamic renal scintigraphy.

Modality
PET/SPECT/Nuclear Medicine
Anatomy
Multi-region
Decision
2025-06-12
FDA-cleared K243863

Opulus™ Lymphoma Precision

Roche Molecular Systems, Inc.

Authorized purpose: Opulus Lymphoma Precision segments and visualizes lesions and measures total metabolic tumor volume in whole-body FDG-PET/CT for patients already diagnosed with FDG-avid lymphoma; trained physicians can accept/reject annotated output, but radiologist review makes the final interpretation and the device is not a screening/diagnostic substitute.

Modality
PET/SPECT/Nuclear Medicine
Anatomy
Whole-body FDG-PET/CT
Decision
2025-05-30
FDA-cleared K241350

Clarify DL

GE Medical Systems Israel, Functional Imaging

Authorized purpose: Clarify DL is a deep-learning reconstruction function intended to reduce noise and improve image quality of nuclear-medicine bone SPECT scintigraphy for all ages on the supported Xeleris V and StarGuide platforms.

Modality
PET/SPECT/Nuclear Medicine
Anatomy
Bone
Decision
2025-01-03
FDA-cleared K243538

uMI Panvivo (uMI Panvivo); uMI Panvivo (uMI Panvivo S)

Shanghai United Imaging Healthcare Co.,Ltd.

Authorized purpose: The uMI Panvivo PET/CT system provides anatomical and functional images. PET depicts the distribution of approved radiopharmaceuticals and CT provides diagnostic tomographic and photon-attenuation information. The FDA indication describes qualified-professional use for detection, localization, evaluation, diagnosis, staging, restaging, monitoring, and follow-up in oncology, infection and inflammation, neurology, and other labeled workflows, plus radiotherapy planning, interventional radiology, and protocol-constrained low-dose lung-cancer screening.

Modality
PET/SPECT/Nuclear Medicine
Anatomy
Whole body and regional anatomy represented in PET/CT studies
Decision
2024-12-12
FDA-cleared K233998

TRAQinform IQ

AIQ Global, Inc.

Authorized purpose: Quantitative single-timepoint or longitudinal analysis of lesion ROIs on adult PET/CT, including volume, density, and tracer-uptake changes, with a report used as an adjunct to local image interpretation.

Modality
PET/SPECT/Nuclear Medicine
Anatomy
Whole body and lesion regions of interest
Decision
2024-09-05
FDA-cleared K241585

uMI Panorama

Shanghai United Imaging Healthcare Co.,Ltd.

Authorized purpose: uMI Panorama GS combines 148 cm axial-field-of-view PET with CT to provide quantitative radiopharmaceutical distribution, diagnostic anatomical and attenuation information, and registered or fused PET/CT images supporting detection, localization, diagnosis, staging, restaging, treatment planning, and treatment-response evaluation. K241585 adds reconstruction, respiratory-motion, CT-less attenuation-correction, quantitative-normalization, quality-control, and AI-expanded-field-of-view functions.

Modality
PET/SPECT/Nuclear Medicine
Anatomy
Multi-region
Decision
2024-08-30
FDA-cleared K242275

syngo.via MI Workflows; Scenium; syngo MBF

Siemens Medical Solutions USA, Inc.

Authorized purpose: syngo.via MI Workflows, Scenium, and syngo MBF are medical diagnostic post-processing applications for viewing, manipulation, quantification, analysis, and comparison of PET or nuclear-medicine functional data with CT or MR anatomical data across timepoints, supporting disease management and radiotherapy treatment planning by trained healthcare professionals.

Modality
PET/SPECT/Nuclear Medicine
Anatomy
Multi-region
Decision
2024-08-30
FDA-cleared K241596

uMI Panvivo

Shanghai United Imaging Healthcare Co., Ltd.

Authorized purpose: The uMI Panvivo is a PET/CT system for anatomical and functional images. PET provides distribution information for approved radiopharmaceuticals and CT provides diagnostic tomographic anatomy and photon attenuation information. The FDA material describes qualified-professional assessment of metabolic and physiologic functions and labeled detection, diagnosis, staging, monitoring, follow-up, radiotherapy-planning, and interventional workflows.

Modality
PET/SPECT/Nuclear Medicine
Anatomy
Whole body and regional anatomy represented in PET/CT studies
Decision
2024-08-15
FDA-cleared K241665

Omni Legend

GE Medical Systems Israel, Functional Imaging

Omni Legend is a PET/CT system for attenuation-corrected PET with positron-emitting radiopharmaceuticals across whole-body, head, heart, brain, lung, breast, bone, gastrointestinal, lymphatic, and other organ workflows; CT can be used for diagnosis, planning, and image fusion.

Modality
PET/SPECT/Nuclear Medicine
Anatomy
Multi-region
Decision
2024-08-08
FDA-cleared K234154

uPMR 790

Shanghai United Imaging Healthcare Co., Ltd.

Authorized purpose: The uPMR 790 combines MR and PET devices to provide registered and fused high-resolution physiologic and anatomic information acquired simultaneously and isocentrically. The FDA indication describes independent MR and PET functionality, MR images of the head, body, and extremities, PET radiopharmaceutical distribution, MR-based attenuation correction, and fused PET/MR reference.

Modality
PET/SPECT/Nuclear Medicine
Anatomy
Head, body, and extremities represented in fused PET/MR studies
Decision
2024-05-24
FDA-cleared K233677

Biograph VK10

Siemens Medical Solutions USA, Inc.

Authorized purpose: The Biograph VK10 combines X-ray CT and PET to register and fuse anatomic and physiologic information, supports independent CT or PET imaging, and aids trained professionals in detecting, localizing, diagnosing, staging, and restaging disease, lesions, tumors, and organ function; the CT may also support radiotherapy planning, interventional procedures, and low-dose lung-cancer screening in high-risk populations.

Modality
PET/SPECT/Nuclear Medicine
Anatomy
Whole body, cardiovascular, neurological, oncologic, and organ-function imaging
Decision
2024-01-12
FDA-cleared K232000

syngo.via MI Workflows; Scenium; syngo MBF

Siemens Medical Solutions USA, Inc.

Authorized purpose: syngo.via MI Workflows VB80A, Scenium VE60, and syngo MBF VB30 support PET, SPECT, nuclear-medicine, CT, and MR viewing, quantification, analysis, longitudinal comparison, organ segmentation, tumor-burden assessment, tau analysis, myocardial blood-flow analysis, and selected radiotherapy-planning support.

Modality
PET/SPECT/Nuclear Medicine
Anatomy
Multi-region
Decision
2023-11-28
FDA-cleared K232712

uMI Panorama

Shanghai United Imaging Healthcare Co., Ltd.

Authorized purpose: uMI Panorama combines PET and CT to provide quantitative radiopharmaceutical distribution, diagnostic anatomical and attenuation information, and fused PET/CT images for qualified healthcare professionals supporting detection, localization, diagnosis, staging, restaging, treatment planning, and treatment-response evaluation across oncology, cardiology, neurology, and other disorders; its CT subsystem can also perform standalone diagnostic imaging and protocol-governed low-dose lung cancer screening.

Modality
PET/SPECT/Nuclear Medicine
Anatomy
Multi-region
Decision
2023-10-03
FDA-cleared K231748

Cartesion Prime (PCD-1000A/3) V10.15

Canon Medical Systems Corporation

Authorized purpose: Cartesion Prime is a PET/CT system for acquisition, reconstruction, fusion, visualization, and professional interpretation within the cleared configuration and radiopharmaceutical workflow.

Modality
PET/SPECT/Nuclear Medicine
Anatomy
Multi-region
Decision
2023-09-12
FDA-cleared K231572

uMI Panorama

Shanghai United Imaging Healthcare Co., Ltd.

Authorized purpose: uMI Panorama GS combines 148 cm axial-field-of-view PET with CT to provide quantitative radiopharmaceutical distribution, diagnostic anatomical and attenuation information, and registered or fused PET/CT images supporting detection, localization, diagnosis, staging, restaging, treatment planning, and treatment-response evaluation in oncology, cardiology, neurology, inflammation, infection, and other disorders. The CT subsystem can also perform standalone diagnostic imaging and protocol-governed low-dose lung cancer screening.

Modality
PET/SPECT/Nuclear Medicine
Anatomy
Multi-region
Decision
2023-07-26
FDA-cleared K231833

Biograph Vision.X and Biograph Vision.X Edge

Siemens Medical Solutions USA, Inc.

Authorized purpose: The Biograph Vision.X and Biograph Vision.X Edge combine X-ray CT and PET to register and fuse anatomic and physiologic information, support independent CT or PET imaging, aid trained professionals in detecting, localizing, diagnosing, staging, and restaging disease, lesions, tumors, and organ function, and support radiotherapy planning, interventional procedures, and low-dose lung-cancer screening in high-risk populations.

Modality
PET/SPECT/Nuclear Medicine
Anatomy
Whole body, cardiovascular, neurological, oncologic, and organ-function imaging
Decision
2023-07-13
FDA-cleared K223212

Precision DL

GE Healthcare

Precision DL uses deep-learning image processing to enhance non-time-of-flight F-18 FDG PET images for clinical oncology review in adults and children.

Modality
PET/SPECT/Nuclear Medicine
Anatomy
Multi-region
Decision
2023-04-27
FDA-cleared K223325

uMI Panorama

Shanghai United Imaging Healthcare Co., Ltd.

Authorized purpose: uMI Panorama combines PET and CT to provide quantitative radiopharmaceutical distribution, diagnostic anatomical and attenuation information, and fused PET/CT images for qualified healthcare professionals supporting detection, localization, diagnosis, staging, restaging, treatment planning, and treatment-response evaluation across oncology, cardiology, neurology, and other disorders; its CT subsystem can also perform standalone diagnostic imaging and protocol-governed low-dose lung cancer screening.

Modality
PET/SPECT/Nuclear Medicine
Anatomy
Multi-region
Decision
2023-03-10
FDA-cleared K221680

Xeleris V Processing and Review System

GE Healthcare

Authorized purpose: The Xeleris V Processing and Review System displays, processes, archives, prints, reports, and networks planar, SPECT, and PET nuclear-medicine data, with optional applications for DaTQUANT, lung analysis, brain analysis, coronary-flow reserve, prostate-cancer bone metastases, liver shunt and dose calculations, and monitoring of patient radiation doses from nuclear-medicine imaging data.

Modality
PET/SPECT/Nuclear Medicine
Anatomy
Whole body, lung, brain, liver, cardiac, coronary, and other anatomy represented in labeled nuclear-medicine studies
Decision
2023-03-01
FDA-cleared K220590

aPROMISE X

EXINI Diagnostics AB

Authorized purpose: aPROMISE X accepts, stores, displays, manipulates, quantifies, and reports digital medical images from nuclear-medicine imaging using PSMA PET/CT, with tools for marking regions of interest and quantitative oncology review by healthcare professionals or researchers.

Modality
PET/SPECT/Nuclear Medicine
Anatomy
Whole-body oncology anatomy represented in PSMA PET/CT studies
Decision
2022-04-29
FDA-cleared K211964

SubtlePET

Subtle Medical, Inc.

SubtlePET is DICOM image-processing software that reduces noise in FDG, amyloid, 18F-DOPA, 18F-DCFPyL, Ga-68 Dotatate, and Ga-68 PSMA PET images for radiologist or nuclear-medicine-physician review.

Modality
PET/SPECT/Nuclear Medicine
Anatomy
Multi-region
Decision
2021-09-28
FDA-cleared K211846

Discovery MI Gen2

GE Medical Systems, LLC.

Authorized purpose: Discovery MI Gen2 acquires and displays PET/CT images of radiopharmaceutical distribution and anatomical structures for qualified nuclear-medicine and radiology professionals within the labeled imaging workflow.

Modality
PET/SPECT/Nuclear Medicine
Anatomy
Whole body and organs represented in Discovery MI PET/CT studies
Decision
2021-08-20
FDA-cleared K212230

TruSPECT Radiological Image Processing Station

Spectrum Dynamics Medical Ltd

Authorized purpose: TruSPECT Radiological Image Processing Station receives, transfers, displays, stores, and processes radioisotope-tracer images for trained professionals in the labeled SPECT workflow.

Modality
PET/SPECT/Nuclear Medicine
Anatomy
Heart and other organs represented in SPECT studies
Decision
2021-08-16
FDA-cleared K211764

Vereos PET/CT

Philips Medical Systems Nederland B.V.

Authorized purpose: Vereos PET/CT detects, localizes, diagnoses, stages, restages, and follows treatment response in oncology, cardiology, and neurology and can provide diagnostic CT and radiotherapy-planning support; optional PET Adaptive Reconstruction is an AI-powered image-reconstruction function.

Modality
PET/SPECT/Nuclear Medicine
Anatomy
Multi-region
Decision
2021-08-06
FDA-cleared K211655

aPROMISE

EXINI Diagnostics AB

Authorized purpose: aPROMISE is a cloud-based platform for healthcare professionals and researchers to accept, transfer, store, display, manipulate, quantify, and report PSMA PET/CT examinations using the PROMISE framework.

Modality
PET/SPECT/Nuclear Medicine
Anatomy
Prostate
Decision
2021-07-27
FDA-cleared K210001

HYPER AiR

Shanghai United Imaging Healthcare Co.,Ltd.

Authorized purpose: HYPER AiR provides the cleared nuclear-medicine image-processing support described in K210001 for supported PET/CT studies; outputs require review by qualified professionals and do not establish product-wide clinical performance.

Modality
PET/SPECT/Nuclear Medicine
Anatomy
Whole body and organs represented in supported PET/CT studies
Decision
2021-04-30
FDA-cleared K203314

Cartesion Prime (PCD-1000A/3) V10.8

Canon Medical Systems Corporation

Authorized purpose: Cartesion Prime is a PET/CT system for acquisition, reconstruction, fusion, visualization, and professional interpretation within the cleared configuration and radiopharmaceutical workflow.

Modality
PET/SPECT/Nuclear Medicine
Anatomy
Multi-region
Decision
2021-04-23
FDA-cleared K201195

syngo.via MI Workflows, syngo MBF

Siemens Medical Solutions USA, Inc.

Authorized purpose: syngo.via molecular-imaging workflows provide viewing, manipulation, quantification, analysis, and comparison of medical images from one or more modalities and time points, including PET or nuclear-medicine functional data and CT or MR anatomical data. The workflows support disease-management activities in oncology, cardiology, neurology, and organ function, and the images or results may aid radiotherapy treatment planning. The submission also describes Scenium neurology review and syngo MBF quantitative myocardial-blood-flow review for supported PET studies.

Modality
PET/SPECT/Nuclear Medicine
Anatomy
Whole-body, cardiac, neurologic, oncologic, organ-function, and radiotherapy-planning anatomy represented in PET, nuclear-medicine, CT, and MR studies
Decision
2020-11-18
FDA-cleared K201103

Xeleris V Processing and Review Systems

GE Healthcare

Authorized purpose: Xeleris V is intended for nuclear-medicine or radiology practitioners and referring physicians to display, process, archive, print, report, and network nuclear-medicine data from gamma cameras or PET scanners. PET or nuclear-medicine data may be registered or fused with CT or MR and physiologic signals to depict, localize, or quantify radionuclide tracers and anatomical structures. The labeled applications include DaTQUANT review of 123I-ioflupane images, Q.Lung support for pulmonary embolism, COPD, emphysema, lung-function assessment, and resection planning, and Q.Brain review of brain metabolic function or blood flow in specified neurologic conditions.

Modality
PET/SPECT/Nuclear Medicine
Anatomy
Whole-body, lung, brain/striatum, and other anatomy represented in nuclear-medicine, PET, CT, and MR studies
Decision
2020-09-25
FDA-cleared K193210

HYPER DLR

Shanghai United Imaging Healthcare Co., Ltd.

Authorized purpose: HYPER DLR is an image-processing function intended for radiologists and nuclear-medicine physicians to reduce noise in fluorodeoxyglucose PET images. The software is intended to be implemented on the previously cleared uMI 550 and uMI 780 PET/CT devices.

Modality
PET/SPECT/Nuclear Medicine
Anatomy
Whole-body FDG PET images
Decision
2020-08-04
FDA-cleared K193248

Biograph Vision, Biograph mCT Family of PET/CTs

Siemens Medical Solutions USA, Inc

Authorized purpose: The Biograph Vision and Biograph mCT family are combined PET/CT systems for acquiring, reconstructing, fusing, displaying, evaluating, and archiving PET and CT studies for trained nuclear-medicine and radiology professionals across labeled oncology, cardiology, neurology, and radiotherapy-planning workflows.

Modality
PET/SPECT/Nuclear Medicine
Anatomy
Multi-region
Decision
2020-02-14
FDA-cleared K193178

Biograph Horizon

Siemens Medical Solution USA, Inc.

Authorized purpose: Biograph Horizon is a PET/CT system for the labeled molecular-imaging acquisition, reconstruction, fusion, visualization, and professional-interpretation workflow.

Modality
PET/SPECT/Nuclear Medicine
Anatomy
Multi-region
Decision
2020-02-12
FDA-cleared K191262

aBSI

EXINI Diagnostics AB

Authorized purpose: aBSI analyzes nuclear-medicine whole-body bone scans and SPECT to mark lesions and quantify skeletal disease burden as a fraction of total skeletal weight for trained professionals and researchers; the cloud release does not accept CT or static partial bone scans.

Modality
PET/SPECT/Nuclear Medicine
Anatomy
Bone
Decision
2019-08-05
FDA-cleared K182336

SubtlePET

Subtle Medical, Inc.

Authorized purpose: SubtlePET V1.0.0 is image-processing software for transfer, storage, and noise reduction of FDG and amyloid PET images, including PET/CT and PET/MR studies.

Modality
PET/SPECT/Nuclear Medicine
Anatomy
Whole-body and brain PET imaging regions, including FDG and amyloid PET studies
Decision
2018-11-30